In a report released yesterday, Mayank Mamtani from B.Riley Financial maintained a Buy rating on Viking Therapeutics (VKTX – Research Report), ...
B.Riley Financial analyst Mayank Mamtani reiterated a Buy rating on Altimmune (ALT – Research Report) yesterday and set a price target of ...
LOS ANGELES, Jan. 21, 2025 /PRNewswire/ -- B. Riley Financial, Inc. (NASDAQ: RILY) ("B. Riley" or the "Company"), a diversified financial services company, today ...
Equities research analysts at B. Riley issued their Q2 2025 earnings per share estimates for shares of Redwire in a report released on Monday, January 27th. B. Riley analyst M. Crawford forecasts that ...
I have covered B. Riley Financial, Inc. or "B. Riley" (NASDAQ:RILY, NASDAQ:RILYL, NASDAQ:RILYP, NASDAQ:RILYM, NASDAQ:RILYK, NASDAQ:RILYN, NASDAQ:RILYG, NASDAQ:RILYT ...
LOS ANGELES, Jan. 21, 2025 /PRNewswire/ -- B. Riley Financial, Inc. (NASDAQ: RILY) ("B. Riley" or the "Company"), a diversified financial services company, today announced the redemption on February ...
B. Riley Financial Inc. suspended dividends on a pair of its preferred shares, holding off on cash payments to some investors ...
RILY Stock Performance and Moving Averages. In recent trading, B Riley Financial Inc (RILY) stock price has shown some volatility, fluctuating 9.29% over the last five trades and ...